查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827838

2025年全球血管支架市場報告

Vascular Stent Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，血管支架市場規模強勁成長，從2024年的158.5億美元增加至2025年的172.5億美元，複合年成長率為8.9%。這段歷史時期的成長得益於臨床研發、藥物釋放型支架(DES)的引進、球囊血管成形術、早期支架創新以及醫師訓練與技能發展。

預計未來幾年血管支架市場將快速成長，到2029年將達到257.1億美元，複合年成長率為10.5%。預測期內成長的主要促進因素包括：對預防性心血管護理的關注、向門診手術的轉變、成本效益和價值驅動型醫療保健、生物可吸收支架和新一代材料以及血管內介入治療的擴展。預測期內的主要趨勢包括：支架塗層和材料的進步、意識提升、向門診病人治療的轉變以及對成本效益的關注。

血管支架是一種精密設計的金屬網狀管，用於醫療手術，以防止狹窄或阻塞的靜脈和動脈閉塞並促進血液流動。這種治療方法通常被稱為“血管置入術”，旨在透過打通阻塞的動脈、降低感染疾病和身體併發症的風險，同時最大限度地降低後期血管再阻塞的風險，從而加快康復。

血管支架產品的主要類別包括冠狀動脈支架、周邊支架和 EVAR血管支架。冠狀動脈支架專門針對向心臟供氧的狹窄動脈，在血管成形術後維持動脈通暢性方面發揮關鍵作用。在血管支架市場，這些支架有多種類型，包括裸金屬支架、生物工程和生物可吸收血管支架、藥物釋放型支架和雙療支架。這些支架由鈷鉻、鉑鉻、鎳鈦、不銹鋼和聚合物等材料製成。球囊擴張支架和自膨式支架可用於門診手術中心、心臟病治療中心和醫院。

2025年春季，美國關稅飆升及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供血管支架市場統計數據，例如全球血管支架行業規模、各地區市場佔有率、競爭對手的血管支架市場佔有率、詳細的血管支架細分市場、市場趨勢和商機，以及您在血管支架行業取得成功所需的數據。本血管支架市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年的預測成長率為10.5%，較我們先前對該市場的預測略有下降0.1%。下降主要源自於美國與其他國家之間關稅的影響。這可能會直接影響美國，導致來自愛爾蘭和新加坡等主要地區的藥物釋放型洗脫聚合物塗層和球囊擴張支架平台的供應鏈中斷，可能導致冠狀動脈和周邊介入治療的價格上漲。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，這種影響也將更加廣泛地顯現。

血管疾病的日益普及預計將推動血管支架市場的未來成長。影響血管（動脈和靜脈）的血管疾病被歸類為心血管疾病 (CVD)。血管支架透過改善富氧血液流向心臟來治療各種血管疾病。例如，美國負責公共衛生的聯邦機構疾病管制與預防中心 (CDC) 在 2023 年 5 月報告稱，2022 年將有約 702,880 人死於心臟病，佔死亡人數的五分之一。因此，心血管疾病 (CVD) 的盛行率將上升，從而推動血管支架市場的成長。

預計不斷成長的醫療支出將推動血管支架市場的成長。醫療支出是指一個國家、組織或個人在特定時期內為醫療相關商品和服務所投入的總資源，通常以貨幣計量。醫療支出的增加可以改善基礎設施，增加醫療設施，並提高公眾認知度，所有這些都會對血管疾病的診斷和治療產生積極影響。例如，2023年6月，管理主要醫療保健項目的美國醫療保險和醫療補助服務中心（CMS）在其《2023-2024年國家醫療支出預測》中報告稱，預計美國今年的醫療支出成長率為5%，明年為5.1%。因此，醫療支出的不斷成長正在推動血管支架市場的發展。

技術進步是推動血管支架市場發展的關鍵趨勢。眾多公司正在投資生物感測設備、尖端整合支架和藥物釋放型冠狀動脈支架系統，以確保競爭優勢。例如，2022年，印度醫療設備製造商Translumina推出了VIVO ISAR，這是一款新一代雙藥、無聚合物塗層支架(DDCS)，在增強安全性的同時，又不犧牲藥物釋放動力學。此支架採用抗氧化劑和降脂劑普羅布考(Probucol)作為釋放Sirolimus(一種血管再阻塞藥物)的載體，打造出一個安全性和有效性均無可挑剔的無聚合物藥物釋放型支架平台。

血管支架市場包括裸金屬支架、生物可吸收支架系統和藥物釋放型球囊的銷售。市場規模還包括服務供應商銷售或包含在其服務產品中的相關產品的價值。僅包括企業之間交易或銷售給最終消費者的產品和服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球血管支架：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球血管支架市場：成長率分析
  • 全球血管支架市場表現：規模與成長，2019-2024
  • 全球血管支架市場預測：2024-2029年、2034年規模與成長
  • 全球血管支架：總目標市場（TAM）

第6章 市場細分

  • 全球血管支架市場（按產品、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 冠狀動脈支架
  • 周邊血管支架
  • EVAR血管支架
  • 全球血管支架市場類型、表現及預測（2019-2024、2024-2029、2034）
  • 裸金屬支架
  • 生物工程支架
  • 生物可吸收血管支架
  • 藥物釋放型支架
  • 雙療法支架
  • 全球血管支架市場（按材料、性能及預測），2019-2024 年、2024-2029 年、2034 年
  • 金屬支架
  • 鈷鉻合金
  • 鉑鉻
  • 鎳鈦合金
  • 防鏽的
  • 聚合物支架
  • 全球血管支架市場（以輸送方式、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 球囊擴張支架
  • 自膨式支架
  • 全球血管支架市場（按最終用戶、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 門診手術中心
  • 心臟中心
  • 醫院
  • 全球血管支架市場：冠狀動脈支架細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 藥物釋放型冠狀動脈支架
  • 裸金屬冠狀動脈支架
  • 全球血管支架市場：周邊血管支架細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 藥物釋放型周邊支架
  • 裸金屬外周支架
  • 全球血管支架市場：EVAR血管支架細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 主髂動脈支架血管支架
  • 開窗覆膜血管支架
  • 分支血管支架

第7章 區域和國家分析

  • 全球血管支架市場：區域表現及預測（2019-2024、2024-2029、2034）
  • 全球血管支架市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 血管支架市場：競爭格局
  • 血管支架市場：公司簡介
    • Medtronic PLC
    • Abbott Laboratories
    • Boston Scientific Corporation
    • BIoTronik SE & Co. KG
    • B. Braun Melsungen AG

第31章：其他領先和創新企業

  • Terumo Corporation
  • Meril Life Sciences Pvt. Ltd.
  • JOTEC GmbH
  • WL Gore & Associates Inc.
  • MicroPort Scientific Corporation
  • Translumina GmbH
  • Lepu Medical Technology Co. Ltd.
  • Purple Medical Solution Pvt. Ltd.
  • Sahajanand Medical Technologies Pvt. Ltd.
  • Stentys SA
  • Osypka AG
  • Cook Medical Inc.
  • Cordis Corporation
  • Endologix Inc.
  • Johnson & Johnson Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年血管支架市場：提供新機會的國家
  • 2029年血管支架市場：細分市場將帶來新機會
  • 2029年血管支架市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r23036u

Vascular stents are intricately designed metal mesh tubes utilized in medical procedures to prevent vessel closure and enhance blood flow in narrowed or blocked veins and arteries. This intervention, commonly referred to as 'vascular stenting,' aims to minimize the risk of late restenosis while supporting swift recovery by widening obstructed arteries, thus reducing the likelihood of infections and physical complications.

The primary categories of vascular stent products include coronary stents, peripheral vascular stents, and EVAR stent grafts. Coronary stents specifically target constricted arteries supplying oxygenated blood to the heart, playing a crucial role in maintaining arterial patency post-angioplasty. Within the vascular stent market, these stents encompass various types such as bare metal stents, bio-engineered and bioresorbable vascular scaffolds, drug-eluting stents, and dual therapy stents. These stents are crafted from materials like cobalt-chromium, platinum-chromium, nickel titanium, stainless steel, and polymers. Their deployment methods involve balloon-expandable and self-expanding stents, utilized across ambulatory surgical centers, cardiac facilities, and hospitals.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The vascular stent market research report is one of a series of new reports from The Business Research Company that provides vascular stent market statistics, including vascular stent industry global market size, regional shares, competitors with a vascular stent market share, detailed vascular stent market segments, market trends and opportunities, and any further data you may need to thrive in the vascular stent industry. This vascular stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vascular stent market size has grown strongly in recent years. It will grow from $15.85 billion in 2024 to $17.25 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to clinical research and development, drug-eluting stents (des), introduction of balloon angioplasty, early stent innovations, physician training and skill development.

The vascular stent market size is expected to see rapid growth in the next few years. It will grow to $25.71 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to focus on preventive cardiovascular care, shift towards outpatient procedures, cost-effectiveness and value-based healthcare, bioabsorbable stents and next-generation materials, expansion of endovascular interventions. Major trends in the forecast period include advancements in stent coatings and materials, patient education and awareness, shift towards outpatient settings, focus on cost-effectiveness.

The forecast of 10.5% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for drug-eluting polymer coatings and balloon-expandable stent platforms, sourced from key regions such as Ireland and Singapore, could lead to higher prices for coronary and peripheral interventions.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing incidence of vascular diseases is expected to drive the vascular stent market's growth in the future. Vascular disease, which affects the blood vessels (both arteries and veins), falls under the category of cardiovascular diseases (CVD). Vascular stents are used to treat various vascular diseases by facilitating the flow of oxygen-rich blood to the heart. For example, in May 2023, the Centers for Disease Control and Prevention (CDC), a federal agency in the United States focused on public health, reported that approximately 702,880 individuals died from heart disease in 2022, which translates to 1 in every 5 deaths. As a result, the rising prevalence of cardiovascular diseases (CVDs) will contribute to the growth of the vascular stent market.

The rise in healthcare expenditure is anticipated to boost the growth of the vascular stent market. Healthcare expenditure refers to the total resources allocated, typically measured in monetary terms, by a country, organization, or individual for healthcare-related goods and services over a specific period. Higher healthcare spending leads to better infrastructure, enhanced healthcare facilities, and increased awareness, all of which positively influence the diagnosis and treatment of vascular diseases. For example, in June 2023, the Centers for Medicare & Medicaid Services (CMS), a U.S.-based organization that administers major healthcare programs, reported in the National Health Expenditure Projections 2023-2024 that health expenditure growth rates in the United States are expected to be 5% this year and 5.1% the following year. Consequently, rising healthcare expenditure is propelling the vascular stent market forward.

Technological advancement is a significant trend gaining traction in the vascular stent market. Numerous companies are investing in bio-sensing devices, state-of-the-art integrated stents, and drug-eluting coronary stent systems to secure a competitive advantage. For example, in 2022, Translumina, a medical equipment manufacturer based in India, introduced the VIVO ISAR, a next-generation dual drug polymer-free coated stent (DDCS) that combines a stent with an enhanced safety profile without sacrificing drug release kinetics. It utilizes Probucol, an antioxidant and lipid-lowering agent, as a carrier to release Sirolimus (an anti-restenosis medication), thus creating a polymer-free drug-eluting stent platform with uncompromised safety and effectiveness.

Major companies are strategically partnering with start-ups and mid-sized firms in the vascular stent market to expand their product and service offerings. Such collaborations and partnership agreements enable companies to enhance their existing product portfolios and extend their geographical reach. For instance, in September 2023, The Electrospinning Company, a UK-based manufacturer of advanced biomaterials for implantable tissue-regenerative devices, collaborated with Relisys Medical Devices, an India-based producer of highly innovative cardiovascular medical devices, to develop groundbreaking products that could enhance cardiovascular care and transform patient outcomes. Through this partnership, the Electrospinning Company's Caladrix technology allows for the deposition of a thin, functional polymer coating without the need for sutures, enabling the manufacturing of vascular stents with improved production rates and yields while maintaining efficacy.

In January 2024, Olympus Corporation, a Japan-based company specializing in the development, manufacture, and sale of medical technology and precision instruments, acquired Taewoong Medical Co., Ltd. for $0.370 billion. This acquisition is intended to strengthen Olympus Corporation's gastrointestinal product portfolio, enhance patient outcomes, and broaden its global market presence in the GI medical device sector. Taewoong Medical Co., Ltd., a manufacturing company based in South Korea, produces vascular stents designed to treat narrowed blood vessels and improve circulation.

Major companies operating in the vascular stent market are Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, Meril Life Sciences Pvt. Ltd., JOTEC GmbH, W. L. Gore & Associates Inc., MicroPort Scientific Corporation, Translumina GmbH, Lepu Medical Technology Co. Ltd., Purple Medical Solution Pvt. Ltd., Sahajanand Medical Technologies Pvt. Ltd., Stentys SA, Osypka AG, Cook Medical Inc., Cordis Corporation, Endologix Inc., Johnson & Johnson Inc., EP Medsystems Inc.

North America was the largest region in the vascular stent market share in 2024. The regions covered in the vascular stent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vascular stent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vascular stent market consists of sales of bare metal stents, bioresorbable scaffold systems, and drug-eluting balloons. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vascular Stent Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vascular stent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vascular stent ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The vascular stent market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Coronary Stents; Peripheral Vascular Stents; Ever Stent Grafts
  • 2) By Type: Bare Metal Stent; Bio-Engineered Stent; Bioresorbable Vascular Scaffold; Drug Eluting Stent; Dual Therapy Stent
  • 3) By Material: Metallic Stents; Cobalt-Chromium; Platinum Chromium; Nickel Titanium; Stainless Steel; Polymers Stents
  • 4) By Mode Of Delivery: Balloon-Expandable Stent; Self-Expanding Stent
  • 5) By End-User: Ambulatory Surgical Center; Cardiac Center; Hospital
  • Subsegments:
  • 1) By Coronary Stents: Drug-Eluting Coronary Stents; Bare Metal Coronary Stents
  • 2) By Peripheral Vascular Stents: Drug-Eluting Peripheral Stents; Bare Metal Peripheral Stents
  • 3) By EVAR Stent Grafts (Endovascular Aneurysm Repair): Aortoiliac Stent Grafts; Fenestrated Stent Grafts; Branch Stent Grafts
  • Companies Mentioned: Medtronic PLC; Abbott Laboratories; Boston Scientific Corporation; Biotronik SE & Co. KG; B. Braun Melsungen AG; Terumo Corporation; Meril Life Sciences Pvt. Ltd.; JOTEC GmbH; W. L. Gore & Associates Inc.; MicroPort Scientific Corporation; Translumina GmbH; Lepu Medical Technology Co. Ltd.; Purple Medical Solution Pvt. Ltd.; Sahajanand Medical Technologies Pvt. Ltd.; Stentys SA; Osypka AG; Cook Medical Inc.; Cordis Corporation; Endologix Inc.; Johnson & Johnson Inc.; EP Medsystems Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Vascular Stent Market Characteristics

3. Vascular Stent Market Trends And Strategies

4. Vascular Stent Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Vascular Stent Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Vascular Stent PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Vascular Stent Market Growth Rate Analysis
  • 5.4. Global Vascular Stent Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Vascular Stent Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Vascular Stent Total Addressable Market (TAM)

6. Vascular Stent Market Segmentation

  • 6.1. Global Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Coronary Stents
  • Peripheral Vascular Stents
  • Evar Stent Grafts
  • 6.2. Global Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bare Metal Stent
  • Bio-engineered Stent
  • Bioresorbable Vascular Scaffold
  • Drug Eluting Stent
  • Dual Therapy Stent
  • 6.3. Global Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metallic Stents
  • Cobalt-Chromium
  • Platinum Chromium
  • Nickel Titanium
  • Stainless Steel
  • Polymers Stents
  • 6.4. Global Vascular Stent Market, Segmentation By Mode of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Balloon-expandable Stent
  • Self-expanding Stent
  • 6.5. Global Vascular Stent Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Ambulatory Surgical Center
  • Cardiac Center
  • Hospital
  • 6.6. Global Vascular Stent Market, Sub-Segmentation Of Coronary Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Eluting Coronary Stents
  • Bare Metal Coronary Stents
  • 6.7. Global Vascular Stent Market, Sub-Segmentation Of Peripheral Vascular Stents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Eluting Peripheral Stents
  • Bare Metal Peripheral Stents
  • 6.8. Global Vascular Stent Market, Sub-Segmentation Of EVAR Stent Grafts (Endovascular Aneurysm Repair), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Aortoiliac Stent Grafts
  • Fenestrated Stent Grafts
  • Branch Stent Grafts

7. Vascular Stent Market Regional And Country Analysis

  • 7.1. Global Vascular Stent Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Vascular Stent Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vascular Stent Market

  • 8.1. Asia-Pacific Vascular Stent Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vascular Stent Market

  • 9.1. China Vascular Stent Market Overview
  • 9.2. China Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vascular Stent Market

  • 10.1. India Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vascular Stent Market

  • 11.1. Japan Vascular Stent Market Overview
  • 11.2. Japan Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vascular Stent Market

  • 12.1. Australia Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vascular Stent Market

  • 13.1. Indonesia Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vascular Stent Market

  • 14.1. South Korea Vascular Stent Market Overview
  • 14.2. South Korea Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vascular Stent Market

  • 15.1. Western Europe Vascular Stent Market Overview
  • 15.2. Western Europe Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vascular Stent Market

  • 16.1. UK Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vascular Stent Market

  • 17.1. Germany Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vascular Stent Market

  • 18.1. France Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vascular Stent Market

  • 19.1. Italy Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vascular Stent Market

  • 20.1. Spain Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vascular Stent Market

  • 21.1. Eastern Europe Vascular Stent Market Overview
  • 21.2. Eastern Europe Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vascular Stent Market

  • 22.1. Russia Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vascular Stent Market

  • 23.1. North America Vascular Stent Market Overview
  • 23.2. North America Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vascular Stent Market

  • 24.1. USA Vascular Stent Market Overview
  • 24.2. USA Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vascular Stent Market

  • 25.1. Canada Vascular Stent Market Overview
  • 25.2. Canada Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vascular Stent Market

  • 26.1. South America Vascular Stent Market Overview
  • 26.2. South America Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vascular Stent Market

  • 27.1. Brazil Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vascular Stent Market

  • 28.1. Middle East Vascular Stent Market Overview
  • 28.2. Middle East Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vascular Stent Market

  • 29.1. Africa Vascular Stent Market Overview
  • 29.2. Africa Vascular Stent Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Vascular Stent Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Vascular Stent Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vascular Stent Market Competitive Landscape And Company Profiles

  • 30.1. Vascular Stent Market Competitive Landscape
  • 30.2. Vascular Stent Market Company Profiles
    • 30.2.1. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Biotronik SE & Co. KG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis

31. Vascular Stent Market Other Major And Innovative Companies

  • 31.1. Terumo Corporation
  • 31.2. Meril Life Sciences Pvt. Ltd.
  • 31.3. JOTEC GmbH
  • 31.4. W. L. Gore & Associates Inc.
  • 31.5. MicroPort Scientific Corporation
  • 31.6. Translumina GmbH
  • 31.7. Lepu Medical Technology Co. Ltd.
  • 31.8. Purple Medical Solution Pvt. Ltd.
  • 31.9. Sahajanand Medical Technologies Pvt. Ltd.
  • 31.10. Stentys SA
  • 31.11. Osypka AG
  • 31.12. Cook Medical Inc.
  • 31.13. Cordis Corporation
  • 31.14. Endologix Inc.
  • 31.15. Johnson & Johnson Inc.

32. Global Vascular Stent Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vascular Stent Market

34. Recent Developments In The Vascular Stent Market

35. Vascular Stent Market High Potential Countries, Segments and Strategies

  • 35.1 Vascular Stent Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Vascular Stent Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Vascular Stent Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer